Biotech

All Articles

Lilly posts even more good records on its own every week insulin possibility

.On the heels of an FDA rejection for its primary competing Novo Nordisk, Eli Lilly is actually push...

IN 8bio stops phase 2 trial, gives up fifty percent of workforce

.Merely a few months after application the 1st individual in a stage 2 test for recently diagnosed g...

Lilly, Haya ink $1B biobuck excessive weight contract to browse black genome

.Eli Lilly's search for being overweight aim ats has actually led it to the dark genome. The Big Pha...

ArsenalBio raises $325M, rotates out of former lead property

.Toolbox Biosciences is actually proceeding up. The tissue treatment provider has actually added $32...

Lilly- backed weight reduction biotech data IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has filed to d...

Aelis' cannabis use drug flunks phase 2b, driving Indivior to reassess $100M possibility

.Aelis Farma's hopes of protecting an easy, beneficial decision on a $100 thousand choice settlement...

ProKidney standstills stage 3 test not needed to have for cell therapy approval

.ProKidney has actually quit some of a pair of stage 3 trials for its cell treatment for renal healt...

Vaxcyte climbs on 'sensational' 31-valent PCV succeed against Pfizer

.Vaxcyte unveiled what experts named "stunning" period 1/2 data for its 31-valent pneumococcal vacci...

Recursion's mind illness test presents insufficient proof of efficiency

.Recursion has actually stumbled with an early examination of its own tech-enabled approach to medic...

Acepodia, Pfizer click on together for chemistry-based tissue treatment

.Contact it a situation of excellent chemistry: Acepodia, a biotech based upon Nobel Prize-winning s...